BioDirection is a privately held medical device company developing novel and rapid point-of-care technologies for the objective diagnosis and management of concussion and other traumatic brain injury (TBI). The company's lead product, the Tbit blood test, delivers biologically-based results shown to accurately confirm a concussion in less than 90 seconds.